Wiseman and collaborators showed that transgenic mice expressing non-glycosylated murine PrPC (G3 mice) were completely resistant to prion disease, and that this alteration was associated to the absence of the first glycosylation site since the elimination of the second site resulted in the efficient transmission of human prions. This evidence concerns the gene PRNP and prion disease.